BackOcuphire Pharma Overview

Ocuphire Pharma Other Liabilities

Ocuphire Pharma's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Ocuphire Pharma Other Liabilities History

Loading

Ocuphire Pharma vs. peers: Other Liabilities Comparison

Loading

Ocuphire Pharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ocuphire Pharma (OCUP) FAQ

Ocuphire Pharma posts a other liabilities of $0 as of September 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Ocuphire Pharma's other liabilities was $0. The latest reading is $0 (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Other Liabilities is one piece of Ocuphire Pharma's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for OCUP's other liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Ocuphire Pharma's other metric pages and overview cover the third.

Judging Ocuphire Pharma against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other liabilities easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.